207 Episodes

  1. Peptide receptor radionuclide therapy for neuroendocrine tumours

    Published: 9/5/2020
  2. Larotrectinib in patients with TRK fusion-positive solid tumours

    Published: 4/7/2020
  3. The future of radiotheranostics

    Published: 3/11/2020
  4. International standards for the analysis of patient-reported outcomes in cancer trials

    Published: 3/3/2020
  5. Presenting symptoms of cancer and stage at diagnosis

    Published: 1/9/2020
  6. Global public and philanthropic investment in childhood cancer research

    Published: 12/4/2019
  7. Cervical cancer in India

    Published: 10/30/2019
  8. Oropharyngeal squamous cell carcinoma

    Published: 10/3/2019
  9. Cancer in small island nations

    Published: 9/3/2019
  10. Advances in radioimmunotherapy

    Published: 8/29/2019
  11. International Neoadjuvant Melanoma Consortium

    Published: 7/2/2019
  12. IMWG consensus on imaging in plasma cell disorders

    Published: 5/29/2019
  13. Digital oncology

    Published: 5/16/2019
  14. Choosing Wisely India

    Published: 4/2/2019
  15. Paediatric vertebral radiotherapy

    Published: 3/5/2019
  16. Malignant plural mesothelioma

    Published: 2/2/2019
  17. CAR T-cell therapy

    Published: 1/3/2019
  18. Cervical cancer screening in older women

    Published: 11/29/2018
  19. Palliative care in oncology

    Published: 10/19/2018
  20. Global review of cancer control

    Published: 9/27/2018

4 / 11

Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.